| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| CAGR | 5.60 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Pharmaceutical Granulation Equipment Market Analysis
The Pharmaceutical Granulation Equipment Market is expected to register a CAGR of 5.6% during the forecast period.
The market is driven by the increasing number of research laboratories, growing healthcare R&D expenditures, and product launches.
The increasing research and development in the field of life sciences and huge public and private funding in the sector are boosting the market's growth. For instance, the Indian Ministry of Science and Technology allocated a budget of INR 40 billion (USD 427.20 million) for the Department of Biotechnology (DBT) of India in the Union Budget for 2023-2024, an INR 1,100 crore budget allocated primarily for biotechnology research and development as well as industrial and entrepreneurship development in the country, which is expected to boost the studied market.
In addition, the National Institute of Health (NIH) invested USD 18,002 million in 2022 compared to USD 17,681 million in 2022 for its research activities associated with various chronic diseases, cancer, cardiology diseases, and Alzheimer's. This investment by government organizations contributes to the rising importance of biopharmaceuticals and thus boosts the demand for pharmaceutical granulation equipment, boosting the market's growth.
Further, the increasing number of pharmaceutical research laboratories is expected to increase the need for granulation equipment for the formulation, thereby boosting market growth. For instance, in October 2023, the National Laboratory of Pharmaceutical Research and Development (PharmaLab) was founded by the ELKH Research Centre for Natural Sciences (TTK). Its primary goal is to pioneer therapeutic and diagnostic solutions. Additionally, PharmaLab focuses on creating eco-friendly and cost-effective methods for producing active substances and drug formulations. These innovations are specifically tailored for treating various diseases, ranging from oncological and immunological to neurological ailments. The establishment of such laboratories tends to increase the demand for granulation equipment, thereby boosting the market's growth.
Moreover, strategic activities by the market players, such as strategic acquisition and partnership for the distribution and commercialization of granulation equipment, are expected to contribute to the market's growth. For instance, in March 2023, Prochem, one of the leaders in API powder handling solutions for various domains, acquired Tapasya. It is a company involved in granulation and a single-stop solution provider of solid formulations for the pharmaceutical, nutraceutical, specialty, agro, and food industries.
Thus, increasing R&D expenditure in pharmaceuticals, the growing establishment of pharmaceutical laboratories, and strategic initiatives taken by the market players are expected to boost the market's growth during the forecast period. However, the high cost of equipment is expected to hinder the market's growth during the forecast period.
Pharmaceutical Granulation Equipment Market Trends
The Pharmaceutical Manufacturing Companies Segment is Expected to Hold a Significant Market Share During the Forecast Period
Advancements in science and technology are augmenting the growth of R&D activities by pharmaceutical companies globally. With the rise in R&D spending and increasing sales of pharmaceuticals in developed countries like the United States and Canada, the pharmaceutical industry is entering a new era of advanced medical development. For instance, in April 2022, Ferring Pharmaceuticals opened its integrated R&D and manufacturing facility in Hyderabad and established it with a total investment of EUR 30 million (USD 32.9 million). The R&D capability includes formulation development, and the manufacturing facility is mainly designed for the oral solid dosage form, where the granulation of active ingredients is a crucial step. Hence, with new manufacturing facilities, the market is expected to grow significantly during the study period.
Furthermore, the initiation of the manufacturing of powders is expected to impact the growth of the market significantly. For instance, in November 2022, Hosokawa Micron Powder Systems took the initial steps to begin more in-house manufacturing. This initiative is expected to result in better quality control and lower costs over time. Hence, the new manufacturing of pharmaceuticals helps to increase the demand for granulation and is expected to grow significantly in the market during the forecast period.
Thus, establishing new manufacturing facilities with new investments and initiation of manufacturing services are expected to increase the need for granulation in pharmaceutical manufacturing, which is expected to propel the market to grow during the forecast period.
Understand The Key Trends Shaping This Market
Download PDF
North America is Expected to Hold Significant Share in the Market During the Forecast Period
North America is expected to hold a significant market share due to increased investments and initiatives by public and private organizations. The US pharmaceutical industry is one of the leaders in developing new medicines. Pharmaceutical Research and Manufacturers of America (PhRMA) member companies remained at the forefront.
The increasing funding from the US government for supporting healthcare is an attributing factor to the growth of the market in the United States. For instance, the Congressional Budget Office 2022 published that research and development spending on pharmaceuticals totaled over USD 78,095 million in the United States. Further, according to Statistics Canada, in October 2023, total R&D spending in the industry reached CAD 0.91 billion (USD 0.67 billion) in 2022. This significant investment in research and development in the pharmaceutical field is expected to drive the market during the study period.
Furthermore, the growing incidence of chronic diseases in the region is expected to increase demand for effective drug treatment and thus boost the demand for the granulation equipment for the final dosage forms, such as tablets and capsules, thereby boosting the market's growth. For instance, according to the American Cancer Society, the prevalence of lung cancer is increasing in the country and reported 238,340 lung cancer cases in 2023 compared to 236,740 in 2022. This data shows a rapid increase in the incidence of cancer cases in the country, and during the forecast period, the incidence of cancer is expected to increase further. Thus, the escalating burden of cancer cases in the country is projected to spur the demand for advanced therapeutics, which is, in turn, projected to foster demand for granulation equipment, thereby boosting the market's growth.
Thus, the increasing research and development spending and growing prevalence of chronic diseases are expected to contribute to the market's growth during the forecast period.
Get Analysis on Important Geographic Markets
Download PDF
Pharmaceutical Granulation Equipment Industry Overview
The market is partially semi-consolidated and consists of several major players. Players in the market are adopting various strategies, such as the launch of granulation equipment, to expand their global footprint and stay competitive. Some of the major players in the market are Alexanderwerk, Anchor Mark Pvt Ltd, Syntegon Technology GmbH, GEA Group, and HOSOKAWA MICRON BV.
Pharmaceutical Granulation Equipment Market Leaders
-
Alexanderwerk
-
Anchor Mark Pvt Ltd
-
Syntegon Technology GmbH
-
GEA Group
-
HOSOKAWA MICRON B.V.
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
Pharmaceutical Granulation Equipment Market News
- March 2024: Adare Pharma Solutions revealed its plans for additional investments in its Pessano facility in Milan, Italy. The highlight of this expansion is the incorporation of a high-shear mixer granulator, which is expected to enhance the facility's existing fluid bed capabilities.
- April 2023: Gerteis is expected to exhibit its advanced dry granulation roller compaction at the COPHEX pharmaceutical and cosmetic trade show in Seoul, South Korea.
Pharmaceutical Granulation Equipment Industry Segmentation
As per the scope of the report, granulation is the process of particle enlargement by agglomeration technique to provide a more homogenous mixture with the formation of granules by agglomeration of fine particles.
The pharmaceutical granulation equipment market is segmented by type, mechanism, end user, and geography. By type, the market is segmented as single pot granulators, high sheer granulators, oscillating granulators, and other types. By mechanism, the market is segmented as dry granulators, wet granulators, and mixture granulators. By end user, the market is segmented as pharmaceutical manufacturing companies, contract manufacturing, and other end users. By geography, the market is segmented as North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report offers the value (USD) for the above segments.
| By Type | Single Pot Granulators | ||
| High Sheer Granulators | |||
| Oscillating Granulators | |||
| Other Types | |||
| By Mechanism | Dry Granulators | ||
| Wet Granulators | |||
| Mixture Granulators | |||
| By End User | Pharmaceutical Manufacturing Companies | ||
| Contract Manufacturing | |||
| Other End Users | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Middle East and Africa | GCC | ||
| South Africa | |||
| Rest of Middle East and Africa | |||
| South America | Brazil | ||
| Argentina | |||
| Rest of South America | |||
Need A Different Region or Segment?
Customize Now
Pharmaceutical Granulation Equipment Market Research FAQs
What is the current Pharmaceutical Granulation Equipment Market size?
The Pharmaceutical Granulation Equipment Market is projected to register a CAGR of 5.60% during the forecast period (2025-2030)
Who are the key players in Pharmaceutical Granulation Equipment Market?
Alexanderwerk, Anchor Mark Pvt Ltd, Syntegon Technology GmbH, GEA Group and HOSOKAWA MICRON B.V. are the major companies operating in the Pharmaceutical Granulation Equipment Market.
Which is the fastest growing region in Pharmaceutical Granulation Equipment Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Pharmaceutical Granulation Equipment Market?
In 2025, the North America accounts for the largest market share in Pharmaceutical Granulation Equipment Market.
What years does this Pharmaceutical Granulation Equipment Market cover?
The report covers the Pharmaceutical Granulation Equipment Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Pharmaceutical Granulation Equipment Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Pharmaceutical Granulation Equipment Industry Report
Statistics for the 2025 Pharmaceutical Granulation Equipment market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Pharmaceutical Granulation Equipment analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
